Nanalysis Scientific Corp. (TSXV: NSCI)
Canada
· Delayed Price · Currency is CAD
0.310
+0.015 (5.08%)
Dec 20, 2024, 9:37 AM EST
Nanalysis Scientific Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
Revenue | 43.01 | 28.47 | 24.82 | 16.04 | 7.87 | 8.36 | Upgrade
|
Revenue Growth (YoY) | 66.25% | 14.69% | 54.72% | 103.75% | -5.86% | -0.20% | Upgrade
|
Cost of Revenue | 32.73 | 24.5 | 14.35 | 5.8 | 2.71 | 2.3 | Upgrade
|
Gross Profit | 10.28 | 3.97 | 10.47 | 10.24 | 5.17 | 6.06 | Upgrade
|
Selling, General & Admin | 10.35 | 11.37 | 12.94 | 7.69 | 6.34 | 5.02 | Upgrade
|
Research & Development | 0.39 | 0.68 | 1.47 | 0.64 | 0.48 | - | Upgrade
|
Operating Expenses | 16.07 | 17.51 | 20.52 | 11.43 | 8.91 | 6 | Upgrade
|
Operating Income | -5.79 | -13.54 | -10.06 | -1.19 | -3.74 | 0.06 | Upgrade
|
Interest Expense | -1.1 | -0.28 | -0.08 | - | - | - | Upgrade
|
Interest & Investment Income | - | - | - | 0 | 0.33 | 0.06 | Upgrade
|
Earnings From Equity Investments | -1.01 | -0.53 | - | - | - | - | Upgrade
|
Currency Exchange Gain (Loss) | 0.18 | -0.17 | -0.16 | -0.04 | -0.02 | -0.21 | Upgrade
|
EBT Excluding Unusual Items | -7.99 | -14.51 | -10.3 | -1.23 | -3.43 | -0.1 | Upgrade
|
Merger & Restructuring Charges | 0.7 | 0.53 | -0.1 | -0.19 | -0.27 | -1.3 | Upgrade
|
Gain (Loss) on Sale of Assets | - | -2.81 | - | - | - | - | Upgrade
|
Other Unusual Items | - | - | - | -0.35 | -0.28 | - | Upgrade
|
Pretax Income | -7.3 | -16.8 | -10.4 | -1.77 | -3.98 | -1.4 | Upgrade
|
Income Tax Expense | 0.99 | -0.01 | -0.48 | - | -0.3 | 0.26 | Upgrade
|
Earnings From Continuing Operations | -8.28 | -16.78 | -9.92 | -1.77 | -3.68 | -1.66 | Upgrade
|
Minority Interest in Earnings | - | 0.59 | 0.81 | - | - | - | Upgrade
|
Net Income | -8.28 | -16.2 | -9.1 | -1.77 | -3.68 | -1.66 | Upgrade
|
Net Income to Common | -8.28 | -16.2 | -9.1 | -1.77 | -3.68 | -1.66 | Upgrade
|
Shares Outstanding (Basic) | 108 | 99 | 92 | 70 | 65 | 56 | Upgrade
|
Shares Outstanding (Diluted) | 108 | 99 | 92 | 70 | 65 | 56 | Upgrade
|
Shares Change (YoY) | 10.64% | 7.25% | 31.35% | 7.77% | 17.42% | 21.89% | Upgrade
|
EPS (Basic) | -0.08 | -0.16 | -0.10 | -0.03 | -0.06 | -0.03 | Upgrade
|
EPS (Diluted) | -0.08 | -0.16 | -0.10 | -0.03 | -0.06 | -0.03 | Upgrade
|
Free Cash Flow | -0.52 | -11.91 | -10.67 | -1.79 | -1.05 | 0.24 | Upgrade
|
Free Cash Flow Per Share | -0.00 | -0.12 | -0.12 | -0.03 | -0.02 | 0.00 | Upgrade
|
Gross Margin | 23.90% | 13.95% | 42.18% | 63.83% | 65.62% | 72.45% | Upgrade
|
Operating Margin | -13.47% | -47.55% | -40.51% | -7.42% | -47.51% | 0.69% | Upgrade
|
Profit Margin | -19.26% | -56.90% | -36.67% | -11.05% | -46.71% | -19.85% | Upgrade
|
Free Cash Flow Margin | -1.20% | -41.85% | -43.00% | -11.18% | -13.34% | 2.82% | Upgrade
|
EBITDA | -8.26 | -13.21 | -8.81 | -0.57 | -3.18 | 0.48 | Upgrade
|
EBITDA Margin | -19.21% | -46.40% | -35.47% | -3.58% | -40.34% | 5.79% | Upgrade
|
D&A For EBITDA | -2.47 | 0.33 | 1.25 | 0.62 | 0.57 | 0.43 | Upgrade
|
EBIT | -5.79 | -13.54 | -10.06 | -1.19 | -3.74 | 0.06 | Upgrade
|
EBIT Margin | -13.47% | -47.55% | -40.51% | -7.42% | -47.51% | 0.69% | Upgrade
|
Revenue as Reported | 43.01 | 28.47 | 24.82 | 16.04 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.